No Data
Revenues Not Telling The Story For Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) After Shares Rise 29%
Is Lionco Pharmaceutical GroupLtd (SHSE:603669) Using Debt Sensibly?
Company Report for the Third Quarter of 2024 (after correction)
Announcement on additional information to the 2024 Third Quarter Report
lionco pharmaceutical group (603669.SH) subsidiary cephalosporin sodium for injection passed the generic drug consistency evaluation.
Lionco Pharmaceutical Group (603669.SH) announced that its wholly-owned subsidiary Hainan Lionco Pharmaceutical Co., Ltd. (referred to as "...
Lingkang Pharmaceutical: Third Quarter Report 2024
Some Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) Shareholders Look For Exit As Shares Take 31% Pounding
No Data
